ACXP vs JNJ: Which Stock is Better?
Side-by-side comparison of Acurx Pharmaceuticals LLC and Johnson & Johnson in 2026
ACXP
Acurx Pharmaceuticals LLC
—
JNJ
Johnson & Johnson
$263.04
Key Metrics Comparison
| Metric | ACXP | JNJ | Winner |
|---|---|---|---|
| Market Cap | $11.32M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ACXP
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACXP or JNJ a better investment?
Comparing ACXP and JNJ: Acurx Pharmaceuticals LLC has a market cap of $11.32M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACXP and JNJ?
ACXP (Acurx Pharmaceuticals LLC) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACXP or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACXP or JNJ?
Both ACXP and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ACXP or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ACXP or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $11.32M for ACXP.
Should I buy ACXP or JNJ in 2026?
Both ACXP and JNJ have investment merit. ACXP trades at $N/A while JNJ trades at $263.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACXP and JNJ stock?
Key differences: Market Cap ($11.32M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ACXP or JNJ in 2026?
The choice between ACXP and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ACXP and JNJ?
ACXP (Acurx Pharmaceuticals LLC) has a market cap of $11.32M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.